Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis

Annals of the Rheumatic Diseases

Volumn 66, Issue 7, 2007, Pages 936-939

  Chandran, Vinod ^a   Bhella, Sita ^b   Schentag, Catherine ^a   Gladman, Dafna D ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRITIS; ARTICLE; CHRONIC ILLNESS THERAPY FATIGUE SCALE; CLINICAL ASSESSMENT TOOL; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONSTRUCT VALIDITY; CORRELATION COEFFICIENT; CRITERION RELATED VALIDITY; CRONBACH ALPHA COEFFICIENT; DISEASE DURATION; DISEASE SEVERITY; FATIGUE; FEMALE; FIBROMYALGIA; FUNCTIONAL ASSESSMENT; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RATING SCALE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; STATISTICAL ANALYSIS; TEST RETEST RELIABILITY; VALIDITY;

AGE FACTORS; ARTHRITIS, PSORIATIC; CHRONIC DISEASE; FATIGUE; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 34347269571     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.065763     Document Type: Article

References (39)

1. Swain MG. Fatigue in chronic disease. Clin Sci (Lond) 2000;99:1-8.
2. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984;65:135-8.
3. Krupp LB, LaRocca NG, Muir J, et al. A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990;17:1450-2.
4. Jones EA. Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma. Hepatology 1995;22:1606-8.
5. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17.
6. Jones SD, Koh WH, Steiner A, Garrett SL, Calin A. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 1996;23:487-90.
7. Suurmeijer TP, Waltz M, Mourn T, Guillemin F, van Sonderen FL, Briancon S, et al. Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum 2001;45:111-21.
8. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA. Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 2004;51:578-85.
9. North American Nursing Diagnosis Association. Nursing diagnoses: definition and classification, 1997-1998. Philadelphia, PA: McGraw-Hill, 1996:58.
10. Belza BL, Henke CJ, Yelin EH, Epstein WV, Gilliss CL. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993;42:93-9.
11. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
12. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999;85:1186-96.
13. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
14. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994;21:9-14.
15. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002;94:528-38.
16. Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA Trial. Arthritis Rheum 2003;48:35-45.
17. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, et al. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 2006;54:1390-400.
18. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006;54:2793-806.
19. Weisman MH, Breedveld FC, Cifaldi MA, Sterz R, Dietz BM, Spencer-Green GT. Improvements in quality of life measures from adalimumab (HUMIRA®) plus methotrexate (MTX) translate into improved physical function and less fatigue in patients with early rheumatoid arthritis (RA). Arthritis Rheum 2005;52(Suppl 9):S395.
20. Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, et al. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 2004;63:1594-600.
21. Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol 2004;31:1896-902.
22. Vasconcelos OM Jr, Prokhorenko OA, Kelley KF, Vo AH, Olsen CH, Dalakas MC, et al. A comparison of fatigue scales in postpoliomyelitis syndrome. Arch Phys Med Rehabil 2006;87:1213-17.
23. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. Evanston, IL: Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, 1997.
24. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-9.
25. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63-74.
26. Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005;32:811-19.
27. Wright V, Moll JMH. Seronegative polyarthritis. Amsterdam: North-Holland, 1976.
28. Gladman DD. Psoriatic arthritis. In: Harris ED, Budd RC, Genovese MC, Firestein GS, Sargent JS, Sledge CB, eds. Kelley's textbook of rheumatology. 7th edn. Philadelphia, PA: WB Saunders, 2005:1155-64.
29. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus. Lupus 1996;5:190-5.
30. Schentag CT, Cichon J, MacKinnon A, Gladman DD, Urowitz MB. Validation and normative data for the 0-10 point scale version of the Fatigue Severity Scale (FSS). Arthritis Rheum 2000;43(Suppl 9):S177.
31. Schentag CT, Beaton M, Rahman P, Husted J, Gladman DD. Fatigue in psoriatic arthritis (PsA). J Rheumatol 1999;26:1627.
32. Schentag C, Gladman DD. Changes in fatigue in psoriatic arthritis: disease activity or fibromyalgia. Arthritis Rheum 2002;46(Suppl 9):S424.
33. Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005;52:3279-89.
34. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006;367:29-35.
35. Gladman DD, Farewell V, Busklla D, Goodman R, Hamilton L, Langevitz P, et al. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990;17:62-4.
36. Gladman DD, Mease PJ, Krueger G, van der Heijde D, Antoni C, Helliwell PS, et al. Outcome measures in psoriatic arthritis. J Rheumatol 2005;32:2262-9.
37. Burkham J, Harris ED. Fibromyalgia: a chronic pain syndrome, In: Harris ED, Budd RC, Genovese MC, Firestein GS, Sargent JS, Sledge CB, eds. Kelley's textbook of rheumatology. 7th edn. Philadelphia, PA: WB Saunders, 2005:522-36.
38. Kleinman L, Zodet MW, Hakim Z, Aledort J, Barker C, Chan K, et al. Psychometric evaluation of the Fatigue Severity Scale for use in chronic hepatitis C. Qual Life Res 2000;9:499-508.
39. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987;62:127-41.